Essex Investment Management Co. LLC Makes New Investment in Everus (NYSE:ECG)

Essex Investment Management Co. LLC purchased a new position in Everus (NYSE:ECG - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 22,751 shares of the company's stock, valued at approximately $1,496,000.

Several other hedge funds and other institutional investors have also modified their holdings of ECG. SRS Capital Advisors Inc. bought a new position in Everus in the fourth quarter worth about $26,000. Principal Securities Inc. acquired a new stake in shares of Everus during the 4th quarter worth approximately $27,000. HighMark Wealth Management LLC bought a new stake in shares of Everus in the 4th quarter worth approximately $28,000. Crews Bank & Trust bought a new stake in shares of Everus in the 4th quarter worth approximately $29,000. Finally, Mendota Financial Group LLC acquired a new position in Everus during the 4th quarter valued at approximately $36,000.

Analysts Set New Price Targets

ECG has been the topic of several analyst reports. Wolfe Research started coverage on Everus in a research note on Tuesday, December 3rd. They issued a "peer perform" rating on the stock. Oppenheimer increased their price objective on shares of Everus from $70.00 to $80.00 and gave the stock an "outperform" rating in a report on Tuesday, January 7th. Finally, Stifel Nicolaus reduced their target price on shares of Everus from $85.00 to $67.00 and set a "buy" rating for the company in a research note on Thursday, February 13th.

Everus Stock Up 1.3 %

Shares of Everus stock opened at $40.05 on Monday. Everus has a 1-year low of $37.18 and a 1-year high of $77.93. The firm's fifty day simple moving average is $60.08. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.50 and a current ratio of 1.58.

Remove Ads

Everus (NYSE:ECG - Get Free Report) last posted its quarterly earnings data on Tuesday, February 11th. The company reported $0.67 earnings per share for the quarter, missing the consensus estimate of $0.73 by ($0.06). On average, analysts predict that Everus will post 2.49 EPS for the current fiscal year.

Insider Transactions at Everus

In other news, CFO Maximillian J. Marcy bought 1,300 shares of the stock in a transaction that occurred on Tuesday, February 25th. The shares were purchased at an average cost of $38.99 per share, with a total value of $50,687.00. Following the completion of the acquisition, the chief financial officer now directly owns 5,508 shares in the company, valued at approximately $214,756.92. The trade was a 30.89 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Edward A. Ryan purchased 1,400 shares of the company's stock in a transaction on Tuesday, February 25th. The stock was acquired at an average price of $38.02 per share, for a total transaction of $53,228.00. Following the completion of the transaction, the director now owns 14,928 shares of the company's stock, valued at $567,562.56. This represents a 10.35 % increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders purchased 3,750 shares of company stock valued at $153,853.

Everus Company Profile

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

Want to see what other hedge funds are holding ECG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Everus (NYSE:ECG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.